戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 I window studies, and use of irinotecan as a radiation sensitizer.
2 binding that functions as a chemotherapy and radiation sensitizer.
3  potential to be developed as a new class of radiation sensitizers.
4  selectively targeting phosphatases as novel radiation sensitizers.
5 ived up to 6 doses of (177)Lu-PSMA-617 and a radiation sensitizer (3-(4-hydroxyphenyl)-2H-1-benzopyra
6  magnetic resonance imaging contrast agents, radiation sensitizers and antigenic peptides for vaccine
7 mics and the discovery of genotype-selective radiation sensitizers and protective agents.
8 he processes by which antimetabolites act as radiation sensitizers and to define the optimal sequenci
9  administration and combination therapy with radiation sensitizers, chemotherapy, and other radionucl
10 d-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance i
11                                    The ideal radiation sensitizer does not exist today.
12 ance imaging (MRI) contrasting reagents, and radiation sensitizers, etc.
13 o-2'-deoxycytidine (gemcitabine) is a potent radiation sensitizer in a variety of solid tumors and tu
14                           AZD7762 was also a radiation sensitizer in multiple tumor xenograft models.
15 deoxycytidine (dFdCyd)] is a potent ionizing radiation sensitizer in solid tumor cells in vitro and i
16 dings, Gd-tex2+ was found to be an efficient radiation sensitizer in studies carried out with HT29 ce
17 mall molecules that act as genotype-specific radiation sensitizers in a multicellular context.
18 nts are excellent candidates to be tested as radiation sensitizers in clinical trials.
19    The taxanes have demonstrated activity as radiation sensitizers in preclinical studies.
20                                        Novel radiation sensitizers, including inhibitors targeting DN
21  these hits are prioritized as lncRNA Glioma Radiation Sensitizers (lncGRS).
22 aproxiral instead of a cytotoxic agent, as a radiation sensitizer, may be advantageous.
23 ived up to 6 doses of (177)Lu-PSMA-617 and a radiation sensitizer (NOX66).
24 whose inhibitors have potential as chemo- or radiation sensitizers or as monotherapy in tumors addict
25 itabine, a potent chemotherapeutic agent and radiation sensitizer, stimulates phosphorylation of the
26  The addition of efaproxiral, a noncytotoxic radiation sensitizer, to WBRT may improve response rates
27 could allow clinical evaluation of potential radiation sensitizers with fewer patients and in shorter
28                                    The ideal radiation sensitizer would have minimal toxicity itself
29                                    The ideal radiation sensitizer would reach the tumor in adequate c